Abstract:The existing therapies for cancer are not remote satisfactory due to drug-resistance in tumors that are malignant. There is a pressing necessity to take a step forward to develop innovative therapies that can complement current ones. Multiple investigations have demonstrated that ferroptosis therapy, a non-apoptotic modality of programmed cell death, has tremendous potential in face of multiple crucial events, such as drug resistance and toxicity in aggressive malignancies. Recently, ferroptosis at the crosswalk of chemotherapy, materials science, immunotherapy, tumor microenvironment, and bionanotechnology has been presented to elucidate its therapeutic feasibility. Given the burgeoning progression of ferroptosis-based nanomedicine, the newest advancements in this field at the confluence of ferroptosis-inducers, nanotherapeutics, along with tumor microenvironment are given an overview. Here, the signaling pathways of ferroptosis-related were first talked about briefly. The emphasis discussion was placed on the pharmacological mechanisms and the nanodrugs design of ferroptosis inducing agents based on multiple distinct metabolism pathways. Additionally, a comprehensive overview of the action mechanisms by which the tumor microenvironment influences ferroptosis was elaborately descripted. Finally, some limitations of current researches and future research directions were also deliberately discussed to provide details about therapeutic avenues for ferroptosis-related diseases along with the design of anti-drugs.

Emerging role of tumor microenvironmental nutrients and metabolic molecules in ferroptosis: Mechanisms and clinical implications

Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment

Ferroptosis and the tumor microenvironment

Emerging Roles of Energy Metabolism in Ferroptosis Regulation of Tumor Cells

Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges

Ferroptosis-mediated Crosstalk in the Tumor Microenvironment Implicated in Cancer Progression and Therapy

Emerging mechanisms and targeted therapy of ferroptosis in cancer

Recent research progress based on ferroptosis-related signaling pathways and the tumor microenvironment on it effects

Ferroptosis and its emerging role in tumor

Metabolic regulation of ferroptosis in the tumor microenvironment

A Promising Future of Ferroptosis in Tumor Therapy

Emerging roles of ferroptosis in the tumor immune landscape: from danger signals to anti-tumor immunity

Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer: Focus on Immunotherapy and Nanotechnology

Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications

Ferroptosis crosstalk in anti-tumor immunotherapy: molecular mechanisms, tumor microenvironment, application prospects

Ferroptosis-Mediated Formation of Tumor-Promoting Immune Microenvironment

The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions

Emerging Mechanisms and Targeted Therapy of Ferroptosis in Neurological Diseases and Neuro-oncology

Recent advances of ferroptosis in tumor: From biological function to clinical application

Emerging mechanisms of ferroptosis and its implications in lung cancer

Ferroptosis in lymphoma: Emerging mechanisms and a novel therapeutic approach